Publications by authors named "Ignacio Duran"

Claim this Profile
A
Avelumab maintenance in advanced urothelial carcinoma: real-world data from Northern Spain (AVEBLADDER study).
Marta Sotelo, Mireia Pelaez, Laura Basterretxea, Estrella Varga, Ricardo Sánchez-Escribano, Ignacio Duran

Clin Transl Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A plain language summary of the TROPiCS-04 study: sacituzumab govitecan use after platinum-based chemotherapy and immunotherapy in people with locally advanced or metastatic cancer of the bladder, urethra, or upper urinary tract.
Thomas Powles, Scott T Tagawa, Christof Vulsteke, Marine Gross-Goupil, Se Hoon Park, Ignacio Duran

Future Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world evidence of nivolumab monotherapy in advanced renal cell carcinoma from a multicenter retrospective cohort study by the Spanish Genitourinary Oncology Group.
Natalia Fernández-Díaz, María Mateos-González, Ana Pertejo-Fernández, Juan Diego Cacho-Lavín, María José Juan-Fita, Ignacio Duran

BMC Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response and Survival With Immune Checkpoint Inhibitor in Patients With Advanced Urothelial Carcinoma and Histology Subtypes.
Dimitra Rafailia Bakaloudi, Rafee Talukder, Thomas Enright, Jacob B Leary, Dimitrios Makrakis, Ignacio Duran

Clin Genitourin Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upcycling Walnut Green Husk: Polyphenol-Rich Extracts from Traditional vs. Organic Crops for Spray-Dried Vegan Additive Development.
Silvia Matiacevich, Ignacio Durán, Marlen Gutiérrez-Cutiño, Javier Echeverría, César Echeverría

Polymers (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective study assessing the role of the androgen receptor in clear cell renal cell cancer patients treated with VEGFR inhibitors in monotherapy.
Lucia Osorio, Tatiana P Grazioso, Guillermo de Velasco, Olatz Etxaniz, Jose Luis Pérez-Gracia

Clin Transl Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmaceutical cost savings from the treatment of oncology patients in clinical trials.
Borja Gómez Mediavilla, Paloma Lanza-León, Virginia Martínez Callejo, David Cantarero-Prieto, María Lanza Postigo

Biomed J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A study to learn how well enfortumab vedotin (EV) with pembrolizumab works and how safe it is in people with advanced urothelial cancer: a plain language summary of the EV-302/KEYNOTE-A39 study.
Thomas Powles, Begoña P Valderrama, Shilpa Gupta, Jens Bedke, Eiji Kikuchi, Ignacio Duran

Future Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC).
Silke Gillessen, Fabio Turco, Ian D Davis, Jason A Efstathiou, Karim Fizazi, Ignacio Duran

Eur Urol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes With Immune Checkpoint Inhibitors in Patients With FGFR2/3, MTAP or ERBB2 Genomic Alterations in Advanced Urothelial Carcinoma.
Rafee Talukder, Dimitra Rafailia Bakaloudi, Dimitrios Makrakis, Leonidas N Diamantopoulos, Thomas Enright, Ignacio Duran

Clin Genitourin Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final Results from SAUL, a Single-arm International Study of Atezolizumab in Unselected Patients with Pretreated Locally Advanced/Metastatic Urinary Tract Carcinoma.
Cora N Sternberg, Yohann Loriot, Ernest Choy, Daniel Castellano, Fernando Lopez-Rios, Ignacio Duran

Eur Urol Focus· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Tumor Mutational Burden and Microsatellite Instability With Response and Outcomes in Patients With Urothelial Carcinoma Treated With Immune Checkpoint Inhibitor.
Dimitra Rafailia Bakaloudi, Rafee Talukder, Dimitrios Makrakis, Leonidas Diamantopoulos, Thomas Enright, Ignacio Duran

Clin Genitourin Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SEOM-GG clinical guidelines for the management of germ-cell testicular cancer (2023).
José Angel Arranz Arija, Xavier García Del Muro, Raquel Luque Caro, María José Méndez-Vidal, Begoña Pérez-Valderrama

Clin Transl Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival following anti-PD-(L)1 monotherapy in advanced urothelial cancer and an assessment of potential prognostic clinical factors: a multicentre observational study.
Chantal F Stockem, Sarah M H Einerhand, Isabel Miras Rodríguez, Youssra Salhi, Esther Pérez, Ignacio Duran

BJC Rep· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RENO Study: Clinical characteristics, treatment patterns and survival results in patients with metastatic renal cell carcinoma in Northern Spain.
Laura Basterretxea Badiola, Nuria Lainez Milagro, Diego Cacho Lavín, Sandra López Peraita, Mikel Arruti Ibarbia, Ignacio Duran

Semin Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Criteria and indicators to evaluate quality of care in genitourinary tumour boards.
Javier Puente, Ferrán Algaba Arrea, Óscar Buisán Rueda, Daniel Castellano Gauna, Ignacio Durán

Clin Transl Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Implications of Blood Immune-Cell Composition in Metastatic Castration-Resistant Prostate Cancer.
Enrique Perez-Navarro, Vincenza Conteduca, Juan M Funes, Jose I Dominguez, Miguel Martin-Serrano, Ignacio Duran

Cancers (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related Quality of Life in Patients with Previously Treated Advanced Urothelial Carcinoma from EV-301: A Phase 3 Trial of Enfortumab Vedotin Versus Chemotherapy.
Jonathan E Rosenberg, Ronac Mamtani, Guru P Sonpavde, Yohann Loriot, Ignacio Duran

Eur Urol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes with atezolizumab in metastatic urothelial cancer: real-world data from a single institution.
Marta Sotelo, Nerea Muñoz-Unceta, Antonio Matorras, Pablo Jara, Clara Castro

Clin Transl Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.
Thomas Powles, Begoña P Valderrama, Shilpa Gupta, Jens Bedke, Eiji Kikuchi, Ignacio Duran

N Engl J Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant chemotherapy with dose-dense MVAC in muscle-invasive bladder cancer: a tertiary center experience.
Marina Serrano, Nerea Muñoz-Unceta, Lucía Andrea Alonso, Ainara Azueta, José Luis Gutiérrez Baños, Ignacio Duran

Clin Transl Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tailored immunotherapy approach with nivolumab with or without nivolumab plus ipilimumab as immunotherapeutic boost in patients with metastatic renal cell carcinoma (TITAN-RCC): a multicentre, single-arm, phase 2 trial.
Marc-Oliver Grimm, Emilio Esteban, Philippe Barthélémy, Manuela Schmidinger, Jonas Busch, Ignacio Duran

Lancet Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study.
Do-Youn Oh, Maria Alsina Maqueda, David I Quinn, Peter J O'Dwyer, Ian Chau, Ignacio Duran

BMC Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): "Real World" Experience.
Dimitra Rafailia Bakaloudi, Rafee Talukder, Genevieve Ihsiu Lin, Dimitrios Makrakis, Leonidas N Diamantopoulos, Ignacio Duran

Clin Genitourin Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results from a Phase 1b/2 Study of Ibrutinib Combination Therapy in Advanced Urothelial Carcinoma.
Nataliya Mar, Yousef Zakharia, Alejandro Falcon, Rafael Morales-Barrera, Begona Mellado, Ignacio Duran

Cancers (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis